Interleukin-6 Covaries Inversely With Cognitive Performance Among Middle-Aged Community Volunteers

Abstract

These findings contribute to a growing body of evidence linking chronic inflammation to poorer cognitive functioning and extend these findings to a midlife community sample, raising the possibility that IL-6 may represent a biomarker for risk of future cognitive decline.